跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MINT-BISOPROLOL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MINT-BISOPROLOL
Authorized
STANDARD
MINT-BISOPROLOL
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
90d185678a8dc4c3
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
90d185678a8dc4c3
Drug Approval Canada Name
MINT-BISOPROLOL
Product Name
MINT-BISOPROLOL
Status
Marketed
Status Date
2019-02-05
Original Market Date
2019-02-05
Din
02465612
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:24.00
Atc Original
C07AB07 BISOPROLOL
Atc Name
c 07 ab 07
Aig Number
0122418001
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
BISOPROLOL FUMARATE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
90d185678a8dc4c3
Type
Standard
Back to Health Canada Approvals